Skip to main content Back to Top
Advertisement

9/19/2017

Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection

Reason for the Shortage

    • Pfizer had Precedex premixed bottles on shortage due to manufacturing delays.
    • Dexmedetomidine 100 mcg/mL vials are not affected by this shortage.

Available Products

    • Precedex in 0.9% Sodium Chloride Injection solution for injection, Pfizer, 4 mcg/mL, 100 mL glass bottle, 10 count, NDC 00409-1660-10
    • Precedex in 0.9% Sodium Chloride Injection solution for injection, Pfizer, 4 mcg/mL, 20 mL glass vial, 10 count, NDC 00409-1660-20
    • Precedex in 0.9% Sodium Chloride Injection solution for injection, Pfizer, 4 mcg/mL, 50 mL glass bottle, 20 count, NDC 00409-1660-50

Estimated Resupply Dates

    • Pfizer has Precedex 4 mcg/mL 20 mL, 50 mL, and 100 mL premixed bottles available.

Updated

Updated September 19, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 22, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins